Bayer AG · XETR:BAYN

Bayer — Fact Sheet (May 2025)

1 slide from Bayer's fact sheet, May 2, 2025

1. Slide 1: Pharmaceuticals – Pipeline Overview (as of May 02, 2025)

   Pharmaceuticals – Pipeline Overview1 (as of May 02, 2025) Phase I Phase II Phase III Sevabertinib (HER2/mEGFR Inhibitor) (BAY 2927088) Sevabertinib (HER2/mEGFR Inhibitor) (BAY 2927088) Darolutamide (AR Inhibitor) Metastatic or Unresectable Solid Tumors With HER2-activating Mutations (panSOHO) Adjuva

Bayer — Fact Sheet (May 2025) on 6ix